Results 231 to 240 of about 659,052 (291)

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

Active surveillance reveals common SARS-CoV-2 infections among cats and dogs from households with human COVID-19 cases in Texas, USA. [PDF]

open access: yesOne Health
Pauvolid-Corrêa A   +21 more
europepmc   +1 more source

One Health Insights into Enterococcus: Antimicrobial Resistance and Virulence in Companion Animals and Their Tutors. [PDF]

open access: yesInt J Mol Sci
Monteiro Marques J   +5 more
europepmc   +1 more source

Everything is everywhere but Escherichia coli adapts to different niches. [PDF]

open access: yesISME J
Monteith W   +6 more
europepmc   +1 more source

Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer. [PDF]

open access: yesNucl Med Commun
Oroujeni M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy